PMV Pharmaceuticals Inc (PMVP)

1.12 +5.66%

PMV Pharmaceuticals Inc (PMVP) is currently trading at $1.12. This represents a gain of 5.66% from the previous session. With a market capitalization of $0.06B, PMVP is a key component of the Health Care sector. Investors looking to trade PMVP should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Get 15 Free Stocks on Moomoo → T&Cs Apply. Trade PMVP commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, PMV Pharmaceuticals Inc (PMVP) shows a bullish trend. Analysts are watching the 1.15 level closely.

Fundamentals
Mkt Cap0.06B
P/E Ratio0.0000
Volume196,456
Others Watching (By Market Cap)
BDTX
Black Diamond T $2.59
+1.57% LNSR
LENSAR Inc $12.14
+1.59% UNCY
Unicycive Thera $6.71
-2.61% APYX
Apyx Medical In $3.42
-3.39% ISPR
Ispire Technolo $2.39
+12.74%
60-Day Technical Chart
Advanced Charting

Need more indicators for PMVP? Use the world's #1 platform.

Open PMVP on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $1
Metric PMVP
+5.66% 		ABTC
+2.94% 		AMC
-1.28% 		FUBO
+1.72%
Price $1.12 $1.05 $1.16 $1.18
Mkt Cap $0.06B $0.97B $0.61B $1.53B
- View → View → View →
Latest Headlines
PMV Pharmaceuticals Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$75m simplywall.st • Nov 3, 2025 PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights GlobeNewswire • Aug 7, 2025 PMV Pharmaceuticals stock rises on positive cancer drug trial data Investing.com • Oct 24, 2025 PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation GlobeNewswire • Sep 10, 2025 Top Penny Stocks To Watch In November 2025 Yahoo Finance • Nov 18, 2025
● Gemini Agentic AI Analyst Insight for PMVP
Market Education
View All Articles →
External Research